Hypoxia promotes 786-O cells invasiveness and resistance to sorafenib via HIF-2α/COX-2. [electronic resource]
- Medical oncology (Northwood, London, England) Jan 2015
- 419 p. digital
Publication Type: Journal Article
1559-131X
10.1007/s12032-014-0419-4 doi
Animals Antineoplastic Agents--therapeutic use Basic Helix-Loop-Helix Transcription Factors--metabolism Cadherins--metabolism Cyclooxygenase 2--metabolism Drug Resistance, Neoplasm Humans Hypoxia--metabolism Kidney Neoplasms--drug therapy Neoplasm Invasiveness Niacinamide--analogs & derivatives Phenylurea Compounds--therapeutic use Snail Family Transcription Factors Sorafenib Transcription Factors--metabolism Tumor Cells, Cultured